FDA reiterates guidance plans on distributed and point-of-care manufacturing
Regulatory NewsJoanne S. Eglovitch
Advanced therapies/cell and gene therapyBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)PharmaceuticalsProduct developmentQuality Assurance and ControlRegulatory Intelligence/PolicyUnited States